ONO PharmaceuticalONO PHARMACEUTICAL CO., LTD.4528東証プライム医薬品FY ending Mar 2024, consolidated, IFRS
Revenue changed +12.4% from the prior year.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and ending equity; net assets approximate parent equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2018 | — | —× | 8.3% | —× | — |
| 2019 | 17.9% | 0.46× | 8.2% | 1.12× | 9.2% |
| 2022 | — | —× | 10.9% | —× | — |
| 2023 | — | —× | 13.9% | —× | — |
| 2024 | 25.5% | 0.56× | 14.3% | 1.12× | 16.0% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
| Item | FY ending Mar 2018 | FY ending Mar 2019 | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 |
|---|---|---|---|---|---|
| Revenue | 261,836 | 288,634 | 361,361 | 447,187 | 502,672 |
| Cost of revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| SG&A | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Pretax income | 63,922 | 65,141 | 105,025 | 143,532 | 163,734 |
| Income tax | — | — | — | — | — |
| Net income attributable to owners | 50,284 | 51,539 | 80,519 | 112,723 | 127,977 |
| Operating margin | — | — | — | — | — |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
| Item | FY ending Mar 2018 | FY ending Mar 2019 | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥65.3B | ¥60B | ¥69.1B | ¥96.1B | ¥166.1B |
| Total assets | ¥609.2B | ¥655.1B | ¥739.2B | ¥882.4B | ¥913.7B |
| Net assets | — | ¥562.7B | — | — | ¥798.6B |
EDINET (FSA Japan)
訂正有価証券報告書－第78期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第75期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第74期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第73期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 10 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.